Stay updated on Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check77 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of investigational dulaglutide doses for type 2 diabetes, and the addition of a new identifier related to Eli Lilly and Company.SummaryDifference11%
Stay in the know with updates to Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.